Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Firefly Bio, Inc.

Firefly Bio, Inc.

Stage unknownSouth San Francisco, CABiotechnology
Facts
Year of incorporation
2022sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Dec 18, 2023
    Form D equity offering · $40.0M (form d sold) · 8 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Firefly Bio, Inc. filed Form D: $39,999,997 sold of $72,000,000, Biotechnology”
Investors on record
1 edges
People
3 officers, 6 directors
Timeline
1
  1. Mar 26, 2024
    Firefly Bio, Inc. filed Form D: $39,999,997 sold of $72,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company